Hafslund Nycomed's Omniscan MRI contrast agent has been certifiedfor marketing in Japan, the Oslo, Norway, company reported thismonth. Nycomed said that Omniscan will be launched by DaiichiPharmaceutical, Nycomed's Japanese licensee, as soon as
Hafslund Nycomed's Omniscan MRI contrast agent has been certified
for marketing in Japan, the Oslo, Norway, company reported this
month. Nycomed said that Omniscan will be launched by Daiichi
Pharmaceutical, Nycomed's Japanese licensee, as soon as final
price approval is granted by Japanese authorities. Nycomed added
that it has submitted an application for marketing approval in
Japan for Visipaque, its third-generation x-ray contrast agent.